Dr. Darrell J. Carmen, MD

Dr. Carmen practices at Minimally Invasive Neurospine and Pain Institute in Riverdale, Georgia.

Dr. Carmen's NPI, 1447368626, was assigned on August 28, 2006. Dr. Carmen graduated from LSU Health Shreveport School of Medicine in 1990. Dr. Carmen's Georgia license number on file is 039749.

Dr. Carmen's primary practice is Minimally Invasive Neurospine and Pain Institute, at 33 Upper Riverdale SW Rd, Riverdale, GA 30274 in Clayton County. The practice phone is (770) 997-0600.

Dr. Carmen's primary practice is Minimally Invasive Neurospine and Pain Institute in Riverdale, Georgia. Dr. Carmen is also affiliated with Southern Regional Medical Center. The medical group on file is Georgia Urology. Dmand AI also links Dr. Carmen to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carmen practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Carmen's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Carmen is board certified in urology by the American Board of Urology. Dmand AI has Dr. Carmen's licenses on file in 4 states: Georgia, U.S. Virgin Islands, Louisiana and Ohio.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse, prostate cancer and testicular dysfunction among the conditions Dr. Carmen treats.

CMS data shows 1,948 Medicare services from Dr. Carmen across 20 procedure codes in 2024, for 532 Medicare patients. Medicare paid $78,054 for them.

CMS counts 532 Medicare patients who saw Dr. Carmen in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Carmen's median patient age at 71, with 19% women.

In 2024, Dr. Carmen wrote 3,629 Medicare Part D claims for 845 patients. 77% of them were for generic drugs. CMS names the drug for 3,455 of them, across 31 drugs with 11 or more claims each, at $3,675,694 in total drug cost. In 2023, CMS named 3,401 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 78 out of 100 for Dr. Carmen for performance year 2024, reported as part of a group. Dr. Carmen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carmen as offering telehealth. CMS counts 17 procedures of prostate resection by Dr. Carmen, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Carmen in 2021. Dr. Carmen's most frequent co-authors are Leslie Allan Deane, FRCSC, MBBS, Robert B. Den, MD and Mark D. Greenberger, MD.

CMS Open Payments shows 676 general payments to Dr. Carmen from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Boston Scientific Corporation paid the most, $2,276.

Dmand AI lists 2 awards for Dr. Carmen, most recently CMS Stage 1 EHR in 2013.

Dr. Carmen graduated from LSU Health Shreveport School of Medicine in 1990. Dr. Carmen is a member of ACS.

Dr. Carmen is in network with 13 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.